Skip to content
Open Access
  • Home
  • Collections
    • High Impact Articles
    • Jawi Collection
    • Malay Medicine
    • Forensic
  • Search Options
    • UiTM Open Access
    • Search by UiTM Scopus
    • Advanced Search
    • Search by Category
  • Discovery Service
    • Sources
    • UiTM Journals
    • List UiTM Journal in IR
    • Statistic
  • About
    • Open Access
    • Creative Commons Licenses
    • COKI | Malaysia Open Access
    • User Guide
    • Contact Us
    • Search Tips
    • FAQs
Advanced
  • Search
  • Correction: NY-ESO-1 Cancer Te...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Correction: NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer

Correction: NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer

Show other versions (1)
Bibliographic Details
Main Authors: Foluso O. Ademuyiwa, Wiam Bshara, Kristopher Attwood, Carl Morrison, Stephen B. Edge, Christine B. Ambrosone, Tracey L. O’Connor, Ellis G. Levine, Anthony Miliotto, Erika Ritter, Gerd Ritter, Sacha Gnjatic, Kunle Odunsi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3561844/?tool=EBI
  • Holdings
  • Description
  • Other Versions (1)
  • Similar Items
  • Staff View

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3561844/?tool=EBI

Similar Items

  • Correction: NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer.
    by: Foluso O. Ademuyiwa, et al.
    Published: (2012-01-01)
  • NY-ESO-1 cancer testis antigen demonstrates high immunogenicity in triple negative breast cancer.
    by: Foluso O Ademuyiwa, et al.
    Published: (2012-01-01)
  • LUD00-014: Phase I Study of recombinant vaccinia-NY-ESO-1 (rV-NY-ESO-1) and recombinant fowlpox-NY-ESO-1 (rF-NY-ESO-1) in patients with NY-ESO-1 or LAGE positive cancers
    by: Knuth A, et al.
    Published: (2004-07-01)
  • Split T cell tolerance against a self/tumor antigen: spontaneous CD4+ but not CD8+ T cell responses against p53 in cancer patients and healthy donors.
    by: Takemasa Tsuji, et al.
    Published: (2011-01-01)
  • Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy
    by: Afsheen Raza, et al.
    Published: (2020-03-01)

© 2020 | Services hosted by the Perpustakaan Tun Abdul Razak, | Universiti Teknologi MARA | Disclaimer


Loading...